Skip to content
MediPen Ltd. logo — company profile

MediPen Ltd.

Founded 2015 United Kingdom Cardiff, United Kingdom 2 employees Biotechnology, Life Sciences

General Information

Company Name MediPen Ltd.
Founded Year 2015
Location United Kingdom Cardiff, United Kingdom
Employees 2
Industries Biotechnology, Life Sciences
Social

BounceWatch is an independent company data service, not affiliated with MediPen Ltd.. To contact MediPen Ltd., visit medipen.co.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MediPen Ltd. compare?

A PDF of MediPen Ltd. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MediPen Ltd. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MediPen Ltd.

MediPen Ltd. is a UK-based biotechnology startup founded in 2015 with a focus on isolating and harnessing the non-psychoactive elements of the cannabis plant. The company is dedicated to expanding access to legal cannabinoids globally and breaking down negative connotations associated with non-psychoactive cannabinoids. With 30,000 users in the UK, MediPen has developed the MediPen® Cannabinoid Vaporizer to provide the highest quality legal cannabinoid experience. The company's research facility in Cardiff allows it to expand its knowledge and develop highly-concentrated multi-cannabinoid products. Despite the absence of specific information about the last investment, the company's dedication to research and development in the cannabinoid space makes it an intriguing prospect for potential investors.

Business keywords: cannabinoid research, vaporizer technology, cannabis industry, non-psychoactive cannabinoids, CBD products, customer care, innovation, cannabis advocacy

No funding data available for MediPen Ltd. yet.

MediPen Ltd. Alternatives & Competitors

View All Alternatives
MediPen Ltd. vs

Kushla helps cannabis brands manufacture fast-acting edible and beverage products Powered by R.E.A.C...

6 employees
Biotechnology, Health and Wellness
MediPen Ltd. vs
FloraWorks
FloraWorks United States

Science-backed cannabinoid innovation for brands | Minor Cannabinoid Supply | GMP & ISO Cert. | CBN,...

Series A
21 employees
Biotechnology, Consumer Goods
MediPen Ltd. vs
Psilera
Psilera United States

Welcome to a new era of mindful medicine.

11 employees
Biotechnology, Life Sciences

FAQ About MediPen Ltd.

MediPen Ltd was established in the UK in 2015 by a dedicated team of cannabinoid experts seeking to isolate and harness the non-psychoactive elements of the cannabis plant for something greater. Our aim is to expand access to legal cannabinoids to users across the globe. As leaders within this indus...
MediPen Ltd. was founded in 2015.
MediPen Ltd. is headquartered in Cardiff, United Kingdom.
MediPen Ltd. operates in Biotechnology and Life Sciences. Its work centres on cannabinoid research, vaporizer technology, cannabis industry and non-psychoactive cannabinoids.
MediPen Ltd. has approximately 2 employees.
Top alternatives and competitors to MediPen Ltd. include Kushla Life Sciences, FloraWorks, Psilera, ZYUS Life Sciences, BioAlberta. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MediPen Ltd. and Kushla Life Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MediPen Ltd., https://bouncewatch.com/company/medipen-ltd, updated 13 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout